-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

624.O1.6 624. Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological: Hodgkin Lymphoma: Retrospective Analyses and Prospective Trials

Symposia: Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Hodgkin lymphoma, Biological therapies, Antibody Therapy, adult, epidemiology, Lymphomas, Non-Biological therapies, Clinical Research, genomics, Chemotherapy, Combination therapy, Diseases, patient-reported outcomes, Therapies, Immunotherapy, therapy sequence, real-world evidence, Adverse Events, Lymphoid Malignancies, young adult , Biological Processes, Monoclonal Antibody Therapy, Study Population, Human
Monday, December 12, 2022: 10:30 AM-12:00 PM
265-268 (Ernest N. Morial Convention Center)
Moderators:
Robin Gasiorowski, MA, FRACP, FRCPA, MBBS, Concord Hospital, University of Sydney and Ramon Garcia-Sanz, University Hospital of Salamanca
Disclosures:
Gasiorowski: MSD: Honoraria; Otsuka: Honoraria; Novartis: Honoraria; Astellas: Honoraria; Janssen: Honoraria; AbbVie: Honoraria; Antengene: Honoraria.
10:30 AM

Lucille Lew-Derivry1*, Pauline Brice2*, Camille Bigenwald3*, Judith Landman-Parker, M.D., Ph.D.4*, Thierry Leblanc, M.D.5*, Florian Chevillon, MD6*, Nicolas Boissel, MD, PhD7 and Aurélie Cabannes-Hamy, MD8*

1Trousseau Hospital, Paris, France
2APHP, Hôpital Saint-Louis, Hemato-Oncologie, Université de Paris, Paris, France
3Gustave Roussy Institute, Villejuif, France
4Pediatric Hematology Oncology Immunology Department, Armand-Trousseau University Hospital, AP-HP, Paris, France
5Pediatric Hematology Unit, Robert-Debré Hospital, AP-HP, Paris, France
6St-Louis Hospital, APHP, Adolescents and Young Adults Hematology Department, Paris, France
7Hematology Adolescent and Young Adult Unit, France, Paris Cedex 10, France
8Hemato-Oncology Department, Andre Mignot Hospital, Le Chesnay, FRA

10:45 AM

Steven I. Park, MD1, Stephen M. Ansell, MD, PhD2, Sharmila Giri3*, Jakub Svoboda, MD4, Stephen D Smith, MD5*, Tatyana Feldman6*, Elizabeth L. Budde, MD, PhD7, Andrew J Ness8*, Yunsik Choi9*, Philip J Bierman, MD10 and Hun Ju Lee, MD11

1Levine Cancer Institute, Department of Hematologic Oncology and Blood Disorders, Wake Forest University, Atrium Health, Charlotte, NC
2Division of Hematology, Mayo Clinic, Rochester, MN
3Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
4Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
5Division of Medical Oncology, Fred Hutchinson Cancer Center/University of Washington, Seattle, WA
6Division of Hematology and Oncology, Hackensack University Medical Center, Hackensack, NJ
7Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
8Department Quantitative Health Sciences, Mayo Clinic, Rochester, MN
9Business School, Meredith College, Raleigh, NC
10Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE
11Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

11:00 AM

Paul J Bröckelmann, MD1*, Ina Bühnen, MSc2,3*, Julia Meissner, MD4*, Karolin Trautmann-Grill, MD5*, Peter Herhaus, MD6*, Teresa V Halbsguth, MD7*, Valdete Schaub, MD8*, Andrea Kerkhoff, MD9*, Stephan Mathas, MD10*, Matthias Bormann, MD11*, Andreas Dickhut, MD12*, Helen Kaul, Dipl.-Math.13*, Michael Fuchs, MD13*, Carsten Kobe, MD14*, Christian Baues, MD15*, Peter Borchmann1, Andreas Engert, MD13 and Bastian von Tresckow, MD16,17

1German Hodgkin Study Group (GHSG) and Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Cologne, Germany
2Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University of Cologne, Faculty of Medicine, Cologne, Germany
3German Hodgkin Study Group (GHSG), Cologne, Germany, Cologne, Germany
4Medicine V, University of Heidelberg, Heidelberg, Germany
5Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany
6Internal Medicine III, School of Medicine, Klinikum rechts der Isar, Technische Universität München, München, Germany
7Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt/M., Franfkurt, Germany
8Medizinische Klinik II, Universitätsklinikum Tübingen, Tübingen, Germany
9Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
10Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany
11Klinikum Bremen Mitte, Bremen, Germany
12Klinikum Fulda, Fulda, Germany
13German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, Faculty of Medicine and University of Cologne, Cologne, Germany
14Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
15Department of Radiooncology and Cyberknife Center, Faculty of Medicine and University of Cologne, Cologne, Germany
16Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
17German Hodgkin Study Group (GHSG), Germany and Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Germany, University Hospital of Cologne, Cologne, Germany

11:15 AM

Robert Stuver, MD1, Laure Michaud, MD2*, Carla Casulo, MD3, Ranjana H. Advani, MD4, Elizabeth L. Budde, MD, PhD5, Paul M. Barr, MD3, Connie Lee Batlevi, MD, PhD6, Philip C Caron, MD, PhD1, Louis S. Constine, MD7, Savita Dandapani, MD, PhD8*, Pamela Drullinsky, MD1*, Jonathan W. Friedberg, MD, MMSc9, Clare Grieve, BA1*, Audrey Hamilton, MD1*, Paul A. Hamlin, MD1, Richard Hoppe, MD10, Steven M. Horwitz, MD1, Niloufer Khan, MD1, Matthew J. Matasar, MD, MS11, Ariela Noy, MD1, M.Lia Palomba, MD12, Heiko Schoder, MD, MBA2*, David J. Straus, MD1, Shreya Vemuri1*, Joachim Yahalom, MD13, Joanna C. Yang, MD14*, Anas Younes, MD15, Andrew D. Zelenetz, MD, PhD1, Craig H. Moskowitz, MD16, Anita Kumar, MD1 and Alison J. Moskowitz, MD1

1Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
3University of Rochester Medical Center, Rochester, NY
4Department of Medicine, Division of Oncology, Stanford University, Stanford, CA
5Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
6Lymphoma Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NEW YORK, NY
7Department of Radiation Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY
8City of Hope, Duarte, CA
9James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
10Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
11215 West 90th St, 14E, Memorial Sloan Kettering Cancer Center, New York, NY
12Lymphoma Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
13Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
14Washtington University in St. Louis, St. Louis
15AstraZeneca, New York, NY
16Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL

11:30 AM

Ranjana H. Advani, MD1, Abraham Avigdor, MD2, Anna Sureda3, David Lavie, MD4*, Stefan Hohaus5,6*, Jan M. Zaucha, MD, PhD7*, Vu Minh Hua8*, Vittorio Ruggero Zilioli, MD9*, Raimundo Gazitua10*, Muhit Özcan11, Amos Odeleye-Ajakaye12*, Uzor C. Ogbu, MBBS, PhD12*, Akash Nahar, MD, MPH12* and Jane N. Winter, MD13

1Division of Oncology, Stanford Cancer Institute, Stanford, CA
2Chaim Sheba Medical Center, Ramat Gan, Israel
3Clinical Hematology Department, Institut Català d'Oncologia L’Hospitalet, Barcelona, Spain
4Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
5Department of Radiological Sciences, Radiotherapy and Hematology, Università Cattolica del Sacro Cuore, Rome, ITA
6Departemt of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
7Department of Hematology and Transplantology, Medical University of Gdańsk, Gdansk, pomerania, Poland
8Lowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia
9Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, IT-MI, Italy
10Instituto Oncológico Fundación Arturo López Pérez, Santiago, Chile
11Ankara University School of Medicine, Ankara, Turkey
12Merck & Co., Inc., Rahway, NJ
13Feinberg School of Medicine, Northwestern University, Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL

11:45 AM

Anna Santarsieri1*, Emily Mitchell2,3*, Katherine Sturgess1*, Pauline Brice4*, Tobias F. Menne, MD PhD5*, Wendy Osborne5*, Thomas Creasey5*, Kirit M. Ardeshna6, Sarah Behan1*, Kaljit Bhuller7*, Stephen Booth8*, Nikesh D. Chavda9*, Graham P. Collins, MBBS, MA, MRCP, FRCPath, DPhil10, Dominic J. Culligan11*, Kate Cwynarski, MD6*, Andrew Davies12*, Abigail Downing13*, David Dutton14*, Michelle Furtado15*, Eve Gallop-Evans13*, Andrew Hodson16*, David Hopkins17*, Hannah Hsu6*, Sunil Iyengar18*, Stephen G. Jones19*, Kim M. Linton20*, Oliver C. Lomas, MD, PhD10, Nicolas Martinez-Calle21*, Abhinav Mathur11*, Pamela McKay, MD17*, Sateesh K. Nagumantry22*, Deirdre O'Mahony23, Elizabeth H. Phillips20*, Neil Phillips24*, John F. Rudge25*, Nimish K. Shah26*, Gwyneth Stafford1*, Alex Sternberg14*, Rachel Trickey13*, Benjamin J. Uttenthal1*, Natasha Wetherall12*, Andrew K. McMillan, MD21, Michael Stratton3*, Elisa Laurenti, PhD2, Peter J. Campbell3* and George A. Follows1*

1Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
2University of Cambridge, Wellcome - Medical Research Council Cambridge Stem Cell Institute, Cambridge, United Kingdom
3Wellcome Sanger Institute, Cambridge, United Kingdom
4APHP, Hôpital Saint-Louis, Hemato-Oncologie, Université de Paris, Paris, France
5Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
6University College London Hospitals NHS Foundation Trust, London, United Kingdom
7University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
8Royal Berkshire Hospital, Reading, United Kingdom
9University Hospital Bristol, Bristol, United Kingdom
10Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, ENG, United Kingdom
11Aberdeen Royal Infirmary, Aberdeen, United Kingdom
12University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
13Velindre Cancer Centre, Cardiff, United Kingdom
14Great Western Hospitals NHS Foundation Trust, Swindon, United Kingdom
15Royal Cornwall Hospital, Truro, United Kingdom
16Ipswich Hospital NHS Trust, Ipswich, United Kingdom
17Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
18Royal Marsden Hospital, London, United Kingdom
19Sherwood Forest Hospitals NHS Foundation Trust, Sutton-in-Ashfield, United Kingdom
20Division of Cancer Sciences, University of Manchester and the Christie Hospital, Manchester, United Kingdom
21Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
22Peterborough City Hospital, Peterborough, United Kingdom
23Cork University Hospital, Cork, Cork, IRL
24Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom
25Department of Earth Sciences, Bullard Laboratories, Cambridge, United Kingdom
26Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom

*signifies non-member of ASH